← Alle mensen

HZ

Huaqiang Zhou

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary ...

JAMA oncology · 1 maart 2026

Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreat...

Lancet (London, England) · 8 november 2025

Tumor-immuunmicro-omgevingsclassificatie naar PD-L1 bij NSCLC

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-07

Izalontamab brengitecan bij lokaal gevorderd of gemetastaseerd NSCLC met actionable genomische alteraties